News Updates

/News Updates/

Robin Tuytten speaks at Bravo and Assaymap Bravo Interest Group

Robin Tuytten, Metabolomic Diagnostics VP Research and Development spoke at the recent Bravo and Assaymap Bravo Interest Group meeting September 2017. Robins talk was entitled ‘Translational metabolomics using AssayMAP and Bravo for operational set up’ This Meeting provided an excellent forum for attendees to share [...]

Metabolomic Diagnostics secures additional $2 million in venture funding

Metabolomic Diagnostics, has secured an additional €1.6 million in from investors to help complete PrePsia™, its new screening test for pre-eclampsia in first time pregnant mothers. This latest funding round is supported by existing investors, SOSventures, Enterprise Equity and Enterprise Ireland as well as a number [...]

Metabolomic Diagnostics Recruitment

Metabolomic Diagnostics have expanded its team by recruiting Paloma Muñiz Ortea and Leslie Brown. Ms. Muñiz Ortea is our R&D Product Development manager. Paloma is trained as an analytical chemist and holds a PhD from the Cork Institute of Technology where she developed analytical methods [...]

Metabolomic Diagnostics to attend SRI 2016 in Montreal, Canada

Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten will attend the SRI’s 63rd Annual Scientific Meeting, which will take place at the Palais des congres de Montreal in Montreal, QC, Canada, from March 16 – 19, 2016. Prof. Louise Kenny of the Irish Centre for Fetal [...]

Dr. Robin Tuytten’s Webinar on Stratification For Pre-eclampsia

Yesterday afternoon, Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten, hosted a complimentary webinar on Stratification for Pre-eclampsia: Lessons Learned from Translation of a Metabolomics Discovery to a Robust LC-MS-20160229 1400-1. The event was hosted by the AACC and sponsored by Agilent Technologies.  

AACC Complimentary Webinar – Stratification For Pre-eclampsia

On February 29th, join Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten, for an informative look at what it takes to translate the results of an unbiased metabolomics discovery study into a robust analytical pipeline centered around a research-use-only, semi-quantitative LC-MS/MS methodology. Registration is complimentary. [...]

Mother Of Invention: Making Maternal Care Matter

Professor Louise Kenny, inventor of Metabolomic Diagnostics revolutionary technology recently spoke to the Health Independent about being a Mother, a Doctor, and an Innovator. The article is reproduced here: Maternal and perinatal disease account for 10 per cent of the global disease burden, yet only [...]

Metabolomic Diagnostics Research Team Wins Award At ISSHP Europe

At the recent International Society For The Study Of Hypertension in Pregnancy Congress in Budapest, Metabolomic Diagnostics submitted a Poster outlining the team’s ongoing Mass Spec Research. We were delighted when our research was recognised by the organising committee with an award as one of [...]

European Funding for Novel Technology

Irish SME wins EU funding for novel test to detect preeclampsia. ec.europa.eu

Diarmuid Cahalane Listed Founding Member of CRDI

Metabolomic Diagnostics’ Diarmuid Cahalane listed founding member of CRDI- Clinical Research Development Ireland.

Load More Posts